About
Stromal Therapeutics AG is a Swiss biotech company developing immunotherapies targeting tissue cytokines produced by stromal cells, with a lead compound showing efficacy in preclinical models of inflammatory heart disease.
Explore Stromal Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.